Tau Peptide (294-305) (human)

H-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-OH

Placeholder

Product Number: 4109331

CAS Number: 1428135-29-8

€ 80.30 – € 131.60

Custom/Bulk Quote
Pack size available

0.5mg, 1mg
Please select pack size:
Add to your inquiry

Product Description

Tau 294-305, KDNIKHVPGGGS, conjugated to KLH via an N-terminal cysteine was tested as anti-tau vaccine. The tau fragment might prevent formation of the beta/beta-helix structure of protofilaments involving residues 306-378.

ADS
Example ADS
ADS lookup
ADS Lookup
MSDS
MSDS
MSDS lookup
MSDS Lookup
Amyloid Beta Peptides & Alzheimer's Disease
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

B.Riteau et al., Int. Immunol., 13, 193 (2001)

First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model.

E. Kontsekova et al., Alzheimers Res. Ther., 6, 44 (2014)

Salt form: Trifluoroacetate

Molecular weight: 1208.32

Chemical Formula: C₅₁H₈₅N₁₇O₁₇

Storage Temperature: < -15°C

Synonyms: Microtubule-Associated Protein Tau (610-621) (human)

One Letter code: KDNIKHVPGGGS

Source: Synthetic

Country

Inquiry List

No products in the list

Discounts

SPECIAL
OFFERS

FAQ's

FAQs

ADS lookup

ADS Lookup

MSDS lookup

MSDS Lookup

Knowledge Center

Knowledge
Center